@entity25 in @entity1 With XXXX .

@entity1 @entity894 @entity1353 @entity3777 @entity27 @entity4531 @entity15 @entity25
Objective: Poor sleep is a frequent symptom in @entity1 with @entity15 ( @entity15 ). The objective of the study was to assess the relationship between nocturnal polysomnographic (PSG) findings and quality of sleep, fatigue, and increased @entity25 among @entity1 with @entity15 . Methods: Clinical characteristics were collected. Pittsburgh Sleep Quality Index (PSQI), @entity3777 ( @entity3777 ), @entity25 ( @entity25 ), and International @entity4531 Rating Scale were used to assess quality of sleep, fatigue, excessive @entity25 , and the presence of @entity4531 ( @entity4531 ). All @entity1 underwent nocturnal diagnostic PSG examination. Results: Fifty @entity1 with @entity15 were enrolled into the study. Age was the only independent variable significantly determining @entity27 index and @entity894 ( @entity894 ) (beta = 0.369, p = 0.010, beta 0.301, p = 0.040). PSQI and @entity25 score were significantly higher in a population with @entity4531 (p = 0.004, p = 0.011). @entity3777 significantly correlated with @entity894 (r = 0.400, p = 0.048). Presence of @entity4531 was the only independent variable significantly determining PSQI and @entity25 (p = 0.005, p = 0.025). @entity894 and presence of @entity4531 were independent variables determining @entity3777 (p = 0.015, p = 0.024). Conclusion: Presence of @entity4531 seems to be the main factor determining poor sleep, fatigue, and daytime somnolence. @entity25 @entity1353 and its severity influences only fatigue in @entity1 with @entity15 .
